Influence of glucoregulation quality on c-reactive protein, interleukin-6 and tumor necrosis factor-α level in patients with diabetes type 1

Background/Aim. Results of studies which have proved an increased inflammatory activity in diabetes type 1, have been published over recent years. One of possible mechanisms that are used to explain chronic inflammation in diabetes is the state of hyperglycemia leading to the enhanced synthesis...

Full description

Saved in:
Bibliographic Details
Main Authors: Mitrović Milena, Ilić Tatjana, Stokić Edita, Novaković-Paro Jovanka, Tomić-Naglić Dragana, Bajkin Ivana, Ičin Tijana
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2011-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2011/0042-84501109756M.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850158442486956032
author Mitrović Milena
Ilić Tatjana
Stokić Edita
Novaković-Paro Jovanka
Tomić-Naglić Dragana
Bajkin Ivana
Ičin Tijana
author_facet Mitrović Milena
Ilić Tatjana
Stokić Edita
Novaković-Paro Jovanka
Tomić-Naglić Dragana
Bajkin Ivana
Ičin Tijana
author_sort Mitrović Milena
collection DOAJ
description Background/Aim. Results of studies which have proved an increased inflammatory activity in diabetes type 1, have been published over recent years. One of possible mechanisms that are used to explain chronic inflammation in diabetes is the state of hyperglycemia leading to the enhanced synthesis of glycosylation end products (AGEs) which activate macrophages, increase the oxidative stress and affect the synthesis of interleukins (IL-1, IL-6), tumor necrosis factor-α (TNF-α) and C-reactive protein (CRP). The aim of the study was to determine the inflammatory markers (CRP, IL-6, TNF-α) in patients with diabetes type 1 and to establish their correlation with glucoregulation parameters and other cardiovascular risk factors as well as to compare them with the healthy controls. Methods. The study included 76 patients with diabetes type 1 and 30 healthy controls. We determined values of inflammatory markers (CRP, IL-6, TNF-α) and glucoregulation parameters (fasting glucose HbA1c). Results. The values of CRP (p = 0.014), IL-6 (p = 0.020) and TNF-α (p = 0.037) were statistically significantly higher in the diabetic patients than in the healthy controls. There was a positive correlation between CRP with postprandial glycemia (p = 0.004); the multivariate regression analysis revealed a statistically significant correlation between CRP and age (p = 0.001), smoking (p = 0.055), fasting glucose (p = 0.021) and triglycerides (p = 0.048) as well as between IL-6 and LDLcholesterol (p = 0,009). No statistically significant correlations were found between glycosilated hemoglobin (HbA1c) and the inflammatory markers (CRP, IL-6 and TNF-α). Conclusion. The patients with type 1 diabetes were found to have a low level of inflammatory activity manifested by the increased values of CRP, IL-6 and TNF-α.
format Article
id doaj-art-646d4e65480144fb8777ca18a0ee3cf9
institution OA Journals
issn 0042-8450
language English
publishDate 2011-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-646d4e65480144fb8777ca18a0ee3cf92025-08-20T02:23:52ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502011-01-0168975676110.2298/VSP1109756MInfluence of glucoregulation quality on c-reactive protein, interleukin-6 and tumor necrosis factor-α level in patients with diabetes type 1Mitrović MilenaIlić TatjanaStokić EditaNovaković-Paro JovankaTomić-Naglić DraganaBajkin IvanaIčin TijanaBackground/Aim. Results of studies which have proved an increased inflammatory activity in diabetes type 1, have been published over recent years. One of possible mechanisms that are used to explain chronic inflammation in diabetes is the state of hyperglycemia leading to the enhanced synthesis of glycosylation end products (AGEs) which activate macrophages, increase the oxidative stress and affect the synthesis of interleukins (IL-1, IL-6), tumor necrosis factor-α (TNF-α) and C-reactive protein (CRP). The aim of the study was to determine the inflammatory markers (CRP, IL-6, TNF-α) in patients with diabetes type 1 and to establish their correlation with glucoregulation parameters and other cardiovascular risk factors as well as to compare them with the healthy controls. Methods. The study included 76 patients with diabetes type 1 and 30 healthy controls. We determined values of inflammatory markers (CRP, IL-6, TNF-α) and glucoregulation parameters (fasting glucose HbA1c). Results. The values of CRP (p = 0.014), IL-6 (p = 0.020) and TNF-α (p = 0.037) were statistically significantly higher in the diabetic patients than in the healthy controls. There was a positive correlation between CRP with postprandial glycemia (p = 0.004); the multivariate regression analysis revealed a statistically significant correlation between CRP and age (p = 0.001), smoking (p = 0.055), fasting glucose (p = 0.021) and triglycerides (p = 0.048) as well as between IL-6 and LDLcholesterol (p = 0,009). No statistically significant correlations were found between glycosilated hemoglobin (HbA1c) and the inflammatory markers (CRP, IL-6 and TNF-α). Conclusion. The patients with type 1 diabetes were found to have a low level of inflammatory activity manifested by the increased values of CRP, IL-6 and TNF-α.http://www.doiserbia.nb.rs/img/doi/0042-8450/2011/0042-84501109756M.pdfdiabetes mellitus, type 1blood glucosec-reactive proteininterleukin-6tumor necrosis factor-alphasensitivity and specificity
spellingShingle Mitrović Milena
Ilić Tatjana
Stokić Edita
Novaković-Paro Jovanka
Tomić-Naglić Dragana
Bajkin Ivana
Ičin Tijana
Influence of glucoregulation quality on c-reactive protein, interleukin-6 and tumor necrosis factor-α level in patients with diabetes type 1
Vojnosanitetski Pregled
diabetes mellitus, type 1
blood glucose
c-reactive protein
interleukin-6
tumor necrosis factor-alpha
sensitivity and specificity
title Influence of glucoregulation quality on c-reactive protein, interleukin-6 and tumor necrosis factor-α level in patients with diabetes type 1
title_full Influence of glucoregulation quality on c-reactive protein, interleukin-6 and tumor necrosis factor-α level in patients with diabetes type 1
title_fullStr Influence of glucoregulation quality on c-reactive protein, interleukin-6 and tumor necrosis factor-α level in patients with diabetes type 1
title_full_unstemmed Influence of glucoregulation quality on c-reactive protein, interleukin-6 and tumor necrosis factor-α level in patients with diabetes type 1
title_short Influence of glucoregulation quality on c-reactive protein, interleukin-6 and tumor necrosis factor-α level in patients with diabetes type 1
title_sort influence of glucoregulation quality on c reactive protein interleukin 6 and tumor necrosis factor α level in patients with diabetes type 1
topic diabetes mellitus, type 1
blood glucose
c-reactive protein
interleukin-6
tumor necrosis factor-alpha
sensitivity and specificity
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2011/0042-84501109756M.pdf
work_keys_str_mv AT mitrovicmilena influenceofglucoregulationqualityoncreactiveproteininterleukin6andtumornecrosisfactoralevelinpatientswithdiabetestype1
AT ilictatjana influenceofglucoregulationqualityoncreactiveproteininterleukin6andtumornecrosisfactoralevelinpatientswithdiabetestype1
AT stokicedita influenceofglucoregulationqualityoncreactiveproteininterleukin6andtumornecrosisfactoralevelinpatientswithdiabetestype1
AT novakovicparojovanka influenceofglucoregulationqualityoncreactiveproteininterleukin6andtumornecrosisfactoralevelinpatientswithdiabetestype1
AT tomicnaglicdragana influenceofglucoregulationqualityoncreactiveproteininterleukin6andtumornecrosisfactoralevelinpatientswithdiabetestype1
AT bajkinivana influenceofglucoregulationqualityoncreactiveproteininterleukin6andtumornecrosisfactoralevelinpatientswithdiabetestype1
AT icintijana influenceofglucoregulationqualityoncreactiveproteininterleukin6andtumornecrosisfactoralevelinpatientswithdiabetestype1